View article

Older patients with advanced cancer who are 100% certain they will be cured pose unique challenges for clinical decision making, but to the authors’ knowledge, the prevalence and correlates of absolute certainty about curability (ACC) are unknown.

Cross‐sectional data were collected in a geriatric assessment trial. ACC was assessed by asking patients, “What do you believe are the chances that your cancer will go away and never come back with treatment?” Response options were 100% (coded as ACC), >50%, 50/50, <50%, 0%, and uncertain. The willingness to bear adversity in exchange for longevity was assessed by asking patients to consider trade‐offs between survival and 2 clinical outcomes that varied in abstractness: 1) maintaining quality of life (QOL; an abstract outcome); and 2) specific treatment‐related toxicities (eg, nausea/vomiting, worsening memory). Logistic regression …